Učitavanje...
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
BACKGROUND: Doxorubicin (Dox) is a chemotherapy drug with limited application due to cardiotoxicity that may progress to heart failure. This study aims to evaluate the role of cardiomyocytes derived from mouse embryonic stem cells (CM-mESCs) in the treatment of Dox-induced cardiomyopathy (DIC) in mi...
Spremljeno u:
| Izdano u: | Stem Cell Res Ther |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5799903/ https://ncbi.nlm.nih.gov/pubmed/29402309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0788-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|